Leelakanok N, Holcombe AL, Lund BC, Gu X, Schweizer ML. Association between polypharmacy and death: A systematic review and meta-analysis. J Am Pharm Assoc (2003). 2017;57(6):729- 738.e710. doi:
10.1016/j.japh.2017.06.002.
Armstrong KS, Temmingh H. Prevalence of and factors associated with antipsychotic polypharmacy in patients with serious mental illness: Findings from a cross-sectional study in an upper-middle-income country. Braz J Psychiatry. 2017;39(4):293-301. doi:
10.1590/1516-4446-2016-2015.
Baek YH, Shin JY. Trends in polypharmacy over 12 years and changes in its social gradients in South Korea. PLoS One. 2018;13(9):e0204018. doi:
10.1371/journal.pone.0204018.
Haider SI, Johnell K, Thorslund M, Fastbom J. Analysis of the association between polypharmacy and socioeconomic position among elderly aged > or =77 years in Sweden. Clin Ther. 2008;30(2):419-427. doi:
10.1016/j.clinthera.2008.02.010.
Assari S, Bazargan M. Race/Ethnicity, Socioeconomic Status, and Polypharmacy among Older Americans. Pharmacy (Basel). 2019;7(2). doi:
10.3390/pharmacy7020041.
Assari S, Helmi H, Bazargan M. Polypharmacy in African American Adults: A National Epidemiological Study. Pharmacy (Basel). 2019;7(2). doi:
10.3390/pharmacy7020033.
Assari S, Moghani Lankarani M. Does multi-morbidity mediate the effect of socioeconomics on self-rated health? Cross-country differences. Int J Prev Med. 2015;6:85. doi:
10.4103/2008-7802.164413.
Assari S. Cross-country variation in additive effects of socio-economics, health behaviors, and comorbidities on subjective health of patients with diabetes. J Diabetes Metab Disord. 2014;13(1):36. doi:
10.1186/2251-6581-13-36.
Assari S, Moghani Lankarani R, Moghani Lankarani M. Cross-country differences in the association between diabetes and disability. J Diabetes Metab Disord. 2014;13(1):3. doi:
10.1186/2251-6581-13-3.
Assari S. Cross-country differences in the additive effects of socioeconomics, health behaviors and medical comorbidities on disability among older adults with heart disease. J Tehran Heart Cent. 2015;10(1):24-33.
Assari S. Combined racial and gender differences in the long-term predictive role of education on depressive symptoms and chronic medical conditions. J Racial Ethn Health Disparities. 2017;4(3):385-396. doi:
10.1007/s40615-016-0239-7.
Zeki Al Hazzouri A, Haan MN, Osypuk T, Abdou C, Hinton L, Aiello AE. Neighborhood socioeconomic context and cognitive decline among older Mexican Americans: results from the Sacramento Area Latino Study on Aging. Am J Epidemiol. 2011;174(4):423- 431. doi:
10.1093/aje/kwr095.
Haan MN, Zeki Al-Hazzouri A, Aiello AE. Life-span socioeconomic trajectory, nativity, and cognitive aging in Mexican Americans: the Sacramento Area Latino Study on Aging. J Gerontol B Psychol Sci Soc Sci. 2011;66 Suppl 1:i102-110. doi:
10.1093/geronb/gbq071.
Zeki Al Hazzouri A, Haan MN, Kalbfleisch JD, Galea S, Lisabeth LD, Aiello AE. Life-course socioeconomic position and incidence of dementia and cognitive impairment without dementia in older Mexican Americans: results from the Sacramento area Latino study on aging. Am J Epidemiol. 2011;173(10):1148-1158. doi:
10.1093/aje/kwq483.
Garcia L, Lee A, Zeki Al Hazzouri A, Neuhaus J, Epstein M, Haan M. The impact of neighborhood socioeconomic position on prevalence of diabetes and pre-diabetes in older Latinos: the Sacramento area Latino study on aging. Hisp Health Care Int. 2015;13(2):77-85. doi:
10.1891/1540-4153.13.2.77.
Afable-Munsuz A, Mayeda ER, Pérez-Stable EJ, Haan MN. Immigrant generation and diabetes risk among Mexican Americans: the Sacramento Area Latino Study on Aging. Am J Public Health. 2013;103(5):e45-52. doi:
10.2105/AJPH.2012.300969.
Rodriquez EJ, Sabado-Liwag M, Pérez-Stable EJ, et al. Allostatic Load, Unhealthy Behaviors, and Depressive Symptoms by Birthplace Among Older Adults in the Sacramento Area Latino Study on Aging (SALSA). J Aging Health. 2019:898264319857995. doi:
10.1177/0898264319857995.
González HM, Haan MN, Hinton L. Acculturation and the prevalence of depression in older Mexican Americans: baseline results of the Sacramento Area Latino Study on Aging. J Am Geriatr Soc. 2001;49(7):948-953. doi:
10.1046/j.1532-5415.2001.49186.x.
Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS. Clinical and social determinants of antipsychotic polypharmacy for Chinese patients with schizophrenia. Pharmacopsychiatry. 2007;40(2):47- 52. doi:
10.1055/s-2007-970062.
Ulley J, Harrop D, Ali A, Alton S, Fowler Davis S. Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review. BMC Geriatr. 2019;19(1):15. doi:
10.1186/s12877-019-1031-4.
Walsh EK, Cussen K. “Take ten minutes”: a dedicated ten minute medication review reduces polypharmacy in the elderly. Ir Med J. 2010;103(8):236-238.
van der Meer HG, Wouters H, Pont LG, Taxis K. Reducing the anticholinergic and sedative load in older patients on polypharmacy by pharmacist-led medication review: a randomised controlled trial. BMJ Open. 2018;8(7):e019042. doi:
10.1136/bmjopen-2017-019042.
Tani H, Uchida H, Suzuki T, Fujii Y, Mimura M. Interventions to reduce antipsychotic polypharmacy: a systematic review. Schizophr Res. 2013;143(1):215-220. doi:
10.1016/j.schres.2012.10.015.
Tranulis C, Skalli L, Lalonde P, Nicole L, Stip E. Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature. Drug Saf. 2008;31(1):7-20. doi:
10.2165/00002018-200831010-00002.